Home › SEC Filings › Current Report (8-K)
Current Report (8-K)
All Current Report (8-K)Annual Report (10-K)Quarterly Report (10-Q)Form 4 Insider TradesSC 13D Beneficial Ownership13F Institutional HoldingsPress ReleasesInsider Cluster ActivityInsider Buy Activity
Theme?
All themes Artificial IntelligenceSemiconductorsQuantum ComputingSpace & SatellitesRobotics & AutomationElectric VehiclesClean & Renewable EnergyBattery & Energy StorageNuclear & FusionCybersecurityCloud & SaaSFintech & PaymentsCrypto & BlockchainGenomics & Gene EditingBiotech & Drug DiscoveryE-commerce & PlatformsStreaming & Digital MediaGaming & EsportsDefense TechCannabis
| Ticker | Type | Sentiment | Impact | Summary | Date |
|---|---|---|---|---|---|
| PHGE | 8-K | neutral | 4/10 | Tessera Defense & Homeland Security formalized employment agreements with CEO Michael Oster and CFO David Rokach on Octo | Oct 7, 2026 |
| DFNS | 8-K | neutral | 2/10 | T3 Defense Inc. appointed Shlomo Zakai as Chief Financial Officer effective October 5, 2026, under a consulting agreemen | Oct 7, 2026 |
| HP | 8-K | bullish | 5/10 | Helmerich & Payne issued a pre-announcement for its fiscal Q4 2026, indicating direct margins for all three operating se | Oct 7, 2026 |
| BFNH | 8-K | neutral | 2/10 | Bioforce Nanosciences Holdings, Inc. (BFNH) disclosed the assignment of an oil and gas lease covering approximately 40.1 | Oct 7, 2026 |
| BUKS | 8-K | neutral | 3/10 | Butler National Corporation announced a $10 million increase in its stock repurchase program, bringing total authorizati | Oct 7, 2026 |
| HLLK | 8-K | bearish | 7/10 | SDR Drone, Inc. disclosed two previously unidentified administrative orders from 2014 (California) and 2018 (South Carol | Oct 7, 2026 |
| VIPZ | 8-K | neutral | 3/10 | VIP Play extended the maturity dates on its outstanding convertible notes totaling $450,000: the Hackel Notes ($300,000) | Oct 7, 2026 |
| CVKD | 8-K | bullish | 6/10 | Cadrenal Therapeutics announced a formal strategic process to maximize shareholder value, engaging Tungsten Advisors as | Oct 7, 2026 |
| PLSE | 8-K | bullish | 6/10 | Pulse Biosciences announced it has achieved its enrollment target of 164 evaluable patients in the NANOPULSE-AF IDE pivo | Oct 7, 2026 |
| JVA | 8-K | neutral | 3/10 | Coffee Holding Co., Inc. announced a share repurchase program authorizing up to $2.5 million in buybacks of its common s | Oct 7, 2026 |
| ALKT | 8-K | neutral | 2/10 | Alkami Technology's Chief Accounting Officer, Prerna Sachdeva, resigned on October 2, 2026, to pursue other opportunitie | Oct 7, 2026 |
| BGLC | 8-K | mixed | 6/10 | BioNexus Gene Lab Corp. (BGLC) entered into a definitive agreement with Ruanyun Edai Technology Inc. (RYET) for an exclu | Oct 7, 2026 |
| RARE | 8-K | bullish | 6/10 | Ultragenyx entered into an asset purchase agreement on October 6, 2026 to sell a Rare Pediatric Disease Priority Review | Oct 7, 2026 |
| COCH | 8-K | neutral | 3/10 | Envoy Medical settled a Delaware Chancery lawsuit with Atlas Merchant Capital SPAC Fund I LP, which alleged it was impro | Oct 7, 2026 |
| ONFO | 8-K | bearish | 6/10 | Onfolio Holdings received a Nasdaq extension until November 23, 2026 to regain compliance with the $2.5 million minimum | Oct 7, 2026 |
| BCDA | 8-K | neutral | 3/10 | BioCardia filed an 8-K announcing a poster presentation of the CardiAMP HF II trial design at the HFSA Annual Scientific | Oct 7, 2026 |
| BMNR | 8-K | neutral | 4/10 | Bitmine Immersion Technologies released its October 2026 Chairman's Message, in which Chairman Tom Lee argues that a ful | Oct 7, 2026 |
| AIB | 8-K | neutral | 4/10 | AIB Data Centers issued a CEO letter highlighting recent milestones including a 12-year, 50 MW agreement with Nebius at | Oct 7, 2026 |
| EFC | 8-K | neutral | 2/10 | Ellington Financial Inc. announced a monthly common dividend of $0.13 per share, payable on November 30, 2026, to holder | Oct 7, 2026 |
| EARN | 8-K | neutral | 2/10 | Ellington Credit Company declared a monthly common distribution of $0.08 per share, payable on November 30, 2026 to shar | Oct 7, 2026 |
| TWAV | 8-K | bullish | 5/10 | TaoWeave announced that its portfolio company Manako Labs has gone live commercially with Avia Thvenin-Ducrot across 124 | Oct 7, 2026 |
| LPBB | 8-K | neutral | 3/10 | Launch Two Acquisition Corp. (LPBB) filed an 8-K to further postpone its extraordinary general meeting from October 7 to | Oct 7, 2026 |
| CERO | 8-K | bearish | 6/10 | CERO Therapeutics Holdings has agreed to sell its wholly-owned operating subsidiary (CERo Therapeutics, Inc.) to SRX Glo | Oct 7, 2026 |
| BLNE | 8-K | neutral | 2/10 | Beeline Holdings announced it will host a stakeholder update call on November 12, 2026 to discuss Q3 2026 financial resu | Oct 7, 2026 |
| BSCL | 8-K | neutral | 1/10 | BILI Social International, Inc. terminated Equiniti Trust Company LLC as its transfer agent and appointed VStock Transfe | Oct 7, 2026 |
| CHAR | 8-K | bullish | 6/10 | Charlton Aria Acquisition Corp (CHAR) entered into a definitive business combination agreement with KQC Quantum, Inc., t | Oct 7, 2026 |
| OPNW | 8-K | neutral | 4/10 | OpenWorld announced a non-binding term sheet for a proposed IP-backed financing of up to $130 million involving BeyondAI | Oct 7, 2026 |
| MXF | 8-K | neutral | 3/10 | The Mexico Fund, Inc. filed its September 2026 monthly summary report via an 8-K (Item 7.01). The fund's NAV fell 7.27% | Oct 7, 2026 |
| FCEL | 8-K | neutral | 3/10 | FuelCell Energy (FCEL) announced the departure of CFO Michael Bishop, effective October 6, 2026, with a six-month transi | Oct 7, 2026 |
| JSPR | 8-K | bullish | 5/10 | Jasper Therapeutics commenced a tender offer to repurchase up to all 12,345,707 outstanding warrants (issued in Sep 2025 | Oct 7, 2026 |